Physician profile
Keval Ray
NPI 1114487147
$7,117.63
in general payments reported to CMS, 2019-2025
10 companies · $6,886 in 2025
The $6,886 reported for 2025 was more than what 98% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $231 · 2025: $6,886.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,664 · Travel and Lodging: $1,911 · Grant: $1,000 · Education: $543.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,664.16 |
| Travel and Lodging | $1,910.97 |
| Grant | $1,000.00 |
| Education | $542.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,828.91 | 2025 | Endurant Iis, Valiant Captivia |
| Stryker Corporation | $1,099.40 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S, Artix Mt |
| Penumbra, INC. | $682.83 | 2025 | Penumbra System, Indigo System |
| Shockwave Medical, INC | $544.93 | 2025 | |
| Boston Scientific Corporation | $463.39 | 2025 | Eluvia, General - Balloons, Ranger |
| Silk Road Medical, INC. | $201.71 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Terumo Medical Corporation | $168.24 | 2025 | Azur Cx Detachable, Glidesheath Slender, Tr Band |
| Baxter Healthcare | $59.55 | 2025 | Preveleak |
| Axogen | $39.12 | 2025 | |
| Inari Medical, INC. | $29.55 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Keval Ray listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.